Curaleaf (OTCMKTS:CURLF) Shares Gap Down – What’s Next?

Posted by on Jun 3rd, 2026

Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report)’s share price gapped down before the market opened on Monday . The stock had previously closed at $3.5050, but opened at $3.31. Curaleaf shares last traded at $3.55, with a volume of 56,641 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research raised Curaleaf from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 5th. Three research analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Strong Buy”.

Get Our Latest Analysis on Curaleaf

Curaleaf Stock Down 1.4%

The stock has a market capitalization of $2.51 billion, a price-to-earnings ratio of -27.62 and a beta of 1.53. The company has a quick ratio of 0.74, a current ratio of 1.56 and a debt-to-equity ratio of 1.05. The firm has a 50-day moving average of $3.00 and a two-hundred day moving average of $2.69.

Curaleaf shares are set to reverse split on Friday, June 5th. The 1-3 reverse split was announced on Tuesday, May 26th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, June 4th.

Curaleaf (OTCMKTS:CURLF – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.17. The firm had revenue of $324.23 million for the quarter, compared to analyst estimates of $316.62 million. Curaleaf had a negative return on equity of 8.11% and a negative net margin of 7.76%. As a group, sell-side analysts anticipate that Curaleaf Holdings, Inc. will post -0.1 earnings per share for the current year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.

Featured Articles

Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.